Inventiva (IVA) Stock Price, Quote, News & History | Benzinga

Inventiva SA (IVA) Stock Price, Quote, News & History

IVANASDAQ

Trade with Public

Trade with Public

$4.60

N/A

At close: Aug 14, 5:00 PM EST

$4.64

0.040.87%

After Hours: Aug 14, 9:28 AM EST

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Compare Options Stock Report

Key Statistics

Open

$4.63

Close

$4.60

Volume / Avg.

573.82K / 980.47K

Day Range

$4.54 - $4.65

52 Wk Range

3.35 - 7.98

Market Cap

$1.10B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

53

Short Interest

0.98%

Days to Cover

2.66

Recent Inventiva SA News

Kura Sushi Posts Weak Q3 Sales, Joins FuelCell Energy And Other Big Stocks Moving Lower In Wednesday’s Pre-Market Session

US stock futures lower with Dow down 500 points. Kura Sushi shares drop after reporting worse-than-expected sales. Other stocks also decline in pre-market.

Avi Kapoor

Super Micro Computer, Summit Therapeutics And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

US stock futures lower, Nasdaq down 1%. Super Micro shares down 8.6% after announcing $7B offering to fund AI orders. Other stocks also down in pre-market trading.

Avi Kapoor

Phreesia, Service Properties Trust, Inventiva And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session

U.S. stock futures rise on Tuesday with Dow futures up 400 points. Phreesia shares fall 26.5% in pre-market after mixed Q4 results and lower sales guidance. Other stocks also decline.

Avi Kapoor

Why Virgin Galactic Shares Are Trading Higher By 6%; Here Are 20 Stocks Moving Premarket

Virgin Galactic reported Q4 revenue of $312,000, missing estimates, but beat EPS expectations. Its second SpaceShip is expected to enter service soon, causing a 6% jump in pre-market trading. Other gainers included ARTL, AFBI, and BIRD, while PEPG and PHR were among the losers.

Avi Kapoor

Zenas Biopharma, Daqo New Energy And Other Big Stocks Moving Lower In Friday's Pre-Market Session

U.S. stock futures down, Zenas Biopharma shares fall 9.5% in pre-market trading due to pricing of public offerings. Other stocks also lower.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-104.88M

Investing Cash Flow (TTM)

-133.19M

Financing Cash Flow (TTM)

241.29M

Free Cash Flow (TTM)

-105.13M

Capital Expenditure (TTM)

-247.00K

Net Change in Cash (TTM)

3.22M

Analyst Trends and Forecast

1

Mar

1

Jul

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.1

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$859.93M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

166.05

PB Ratio (TTM)

-

Earnings Yield % (TTM)

-47.68%

Earnings Yield % (FWD)

-

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

-$0.14

Company Debt

Total Debt

$57.09M

LT Debt

$26.82M

LT Debt Issuance (TTM)

$0

LT Debt Repayment (TTM)

-$5.98M

Total Cash

$99.31M

Debt to Equity

-

Issuance of Debt (TTM)

-$5.98M

Repayment of Debt (TTM)

-$5.98M

Key Statistics

Open

$4.63

Close

$4.60

Volume / Avg.

573.82K / 980.47K

Day Range

$4.54 - $4.65

52 Wk Range

3.35 - 7.98

Market Cap

$1.10B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

53

Short Interest

0.98%

Days to Cover

2.66

About

Sector

Health Care

Industry

Biotechnology

Inventiva SA is a France-based clinical-stage biopharmaceutical company focused on the development of oral small-molecule therapies for the treatment of MASH. The wholly-owned research and development facility and a team with expertise and experience...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Inventiva (IVA) stock?

A

You can purchase shares of Inventiva (NASDAQ:IVA) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Inventiva (IVA) competitors?

A

Other companies in Inventiva’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).

Q

What is the forecast, or price target, for Inventiva (IVA) stock?

A

Inventiva has a consensus price target of $14.71.

Q

What is the current price for Inventiva (IVA)?

A

The stock price for Inventiva (NASDAQ: IVA) is $4.64 last updated August 14, 2026 at 9:28 AM EDT.

Q

Does Inventiva (IVA) pay a dividend?

A

There are no upcoming dividends for Inventiva.

Q

When is Inventiva (NASDAQ:IVA) reporting earnings?

A

Inventiva does not have any upcoming earnings scheduled.

Q

Is Inventiva (IVA) going to split?

A

There is no upcoming split for Inventiva.

Q

What sector and industry does Inventiva (IVA) operate in?

A

Inventiva is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.